Table 2.
Polysomnography parameters and sleep diary measures for all subjects together (n = 29) prior to and after 1 mo on gonadotropin-releasing hormone agonist therapy by vasomotor symptom frequency group
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.